Business
Cantargia to Participate at Leerink Partners Global Healthcare Conference
LUND, SE / ACCESS Newswire / January 28, 2026 /Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm:CANTA)(STO:CANTA) today announced that members of Cantargias management will participate in one-on-one meetings at the Leerink Partners Global Healthcare ...
About this update from Cantargia Ab
[{"type":"text","content":"LUND, SE / ACCESS Newswire / January 28, 2026 / Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm:CANTA)(STO:CANTA) today announced that members of Cantargias management will participate in one-on-one meetings at the Leerink Partners Global Healthcare Conference in Miami, Florida on Wednesday, March 11, 2026.","length":322,"tagName":"p"},{"type":"text","content":"For further information, please contactHilde Steineger, CEOTelephone: +46 (0)46-275 62 60E-mail: [email protected]","length":118,"tagName":"p"},{"type":"text","content":"About CantargiaCantargia AB (publ), reg. no. 556791-6019, is a biotechnology company that develops antibody-based treatments for life-threatening diseases and has established a platform based on the protein IL1RAP, involved in a number of cancer forms and inflammatory diseases. Cantargia's oncology program, the antibody nadunolimab (CAN04), is being studied clinically, primarily in combination with chemotherapy with a focus on pancreatic cancer, non-small cell lung cancer and triple-negative breast cancer. Positive data for the combinations indicate stronger efficacy than would be expected from chemotherapy alone. Cantargia's second development program, the antibody CAN10, blocks signaling via IL1RAP in a different manner than nadunolimab and addresses treatment of serious autoimmune/inflammatory diseases. In September 2025, the acquisition of CAN10 by Otsuka Pharmaceutical was completed.","length":910,"tagName":"p"},{"type":"text","content":"Cantargia is listed on Nasdaq Stockholm (ticker: CANTA). More information about Cantargia is available at www.cantargia.com.","length":124,"tagName":"p"},{"type":"text","content":"AttachmentsCantargia to participate at Leerink Partners Global Healthcare Conference","length":85,"tagName":"p"},{"type":"text","content":"SOURCE: Cantargia","length":17,"tagName":"p"},{"type":"text","content":"View the original press release on ACCESS Newswire","length":50,"tagName":"p"}]